{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:57:53Z","timestamp":1790722673597,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Fujian Provincial Natural Science Foundation of China.","award":["No.2024J011524"],"award-info":[{"award-number":["No.2024J011524"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07970-8","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:20:38Z","timestamp":1790673638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PDK4-Associated Metabolic Reprogramming Contributes to Lactate Accumulation and Parthanatos-Related Changes in Septic Cardiomyocytes"],"prefix":"10.1007","author":[{"given":"Shaodong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfa","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"8","key":"7970_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"7970_CR2","doi-asserted-by":"publisher","first-page":"1785463","DOI":"10.3389\/fimmu.2026.1785463","volume":"17","author":"F Cao","year":"2026","unstructured":"Cao F, Yan T, Liang C, et al. Sepsis-induced cardiomyopathy: mechanisms, epidemiology, diagnosis, and treatments. Front Immunol. 2026;17:1785463. https:\/\/doi.org\/10.3389\/fimmu.2026.1785463.","journal-title":"Front Immunol"},{"key":"7970_CR3","doi-asserted-by":"publisher","first-page":"1805393","DOI":"10.3389\/fcvm.2026.1805393","volume":"13","author":"J Zhang","year":"2026","unstructured":"Zhang J, Sheng S, Luo W, et al. Therapeutical progress in sepsis-induced cardiomyopathy. Front Cardiovasc Med. 2026;13:1805393. https:\/\/doi.org\/10.3389\/fcvm.2026.1805393.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"7970_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11886-020-01277-2","volume":"22","author":"M L\u2019Heureux","year":"2020","unstructured":"L\u2019Heureux M, Sternberg M, Brath L, et al. Sepsis-induced cardiomyopathy: a comprehensive review. Curr Cardiol Rep. 2020;22(5):35. https:\/\/doi.org\/10.1007\/s11886-020-01277-2.","journal-title":"Curr Cardiol Rep"},{"issue":"11","key":"7970_CR5","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/biomedicines13112643","volume":"13","author":"K Pamporis","year":"2025","unstructured":"Pamporis K, Karakasis P, Pantelidaki A, et al. Sepsis-induced cardiomyopathy and cardiac arrhythmias: pathophysiology and implications for novel therapeutic approaches. Biomedicines. 2025;13(11):2665. https:\/\/doi.org\/10.3390\/biomedicines13112643.","journal-title":"Biomedicines"},{"key":"7970_CR6","doi-asserted-by":"publisher","first-page":"1779575","DOI":"10.3389\/fimmu.2026.1779575","volume":"17","author":"Y Qiu","year":"2026","unstructured":"Qiu Y, Bi H, Xie W, et al. The immunometabolic axis of sepsis-related myocardial injury: macrophage reprogramming as a central mechanism and therapeutic target. Front Immunol. 2026;17:1779575. https:\/\/doi.org\/10.3389\/fimmu.2026.1779575.","journal-title":"Front Immunol"},{"issue":"14","key":"7970_CR7","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.3390\/ijerph18147598","volume":"18","author":"W Wasyluk","year":"2021","unstructured":"Wasyluk W, Nowicka-St\u0105\u017cka P, Zwolak A. Heart metabolism in sepsis-induced cardiomyopathy\u2014unusual metabolic dysfunction of the heart. Int J Environ Res Public Health. 2021;18(14):7598.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"7970_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbrc.2015.12.113","volume":"469","author":"H Park","year":"2016","unstructured":"Park H, Jeoung NH. Inflammation increases pyruvate dehydrogenase kinase 4 (PDK4) expression via the Jun N-terminal kinase (JNK) pathway in C2C12 cells. Biochem Biophys Res Commun. 2016;469(4):1049\u201354. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.113.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"7970_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3760\/cma.j.cn101460-20251117-00095","volume":"10","author":"L Shengnan","year":"2026","unstructured":"Shengnan L, Yizhi Z, Hui L, et al. Research progress on the role of pyruvate dehydrogenase kinase 4 in myocardial energy metabolism in heart failure. Chin J Heart Fail Cardiomyopathy. 2026;10(1):73\u20138. https:\/\/doi.org\/10.3760\/cma.j.cn101460-20251117-00095.","journal-title":"Chin J Heart Fail Cardiomyopathy"},{"key":"7970_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.22.25336402","author":"N Xu","year":"2025","unstructured":"Xu N, Gan L, Feng Y, et al. PDK4-mediated VDAC2 lactylation links glycolysis to autophagy failure in septic cardiomyopathy. medRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.09.22.25336402.","journal-title":"medRxiv"},{"key":"7970_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1196\/annals.1427.014","volume":"1147","author":"SA Andrabi","year":"2008","unstructured":"Andrabi SA, Dawson TM, Dawson VL. Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann N Y Acad Sci. 2008;1147:233\u201341. https:\/\/doi.org\/10.1196\/annals.1427.014.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"7970_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-021-04109-w","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu L, Li J, Ke Y, et al. The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis. Cell Mol Life Sci. 2022;79(1):60. https:\/\/doi.org\/10.1007\/s00018-021-04109-w.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"7970_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41593-026-02201-7","volume":"29","author":"JW Mace","year":"2026","unstructured":"Mace JW, Gadani SP, Smith MD, et al. Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos. Nat Neurosci. 2026;29(4):796\u2013809. https:\/\/doi.org\/10.1038\/s41593-026-02201-7.","journal-title":"Nat Neurosci"},{"issue":"1","key":"7970_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41419-023-05581-x","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Li Y, Zhang Q, et al. Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I. Cell Death Dis. 2023;14(1):50. https:\/\/doi.org\/10.1038\/s41419-023-05581-x.","journal-title":"Cell Death Dis"},{"key":"7970_CR15","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.bcp.2024.116174","volume":"228","author":"L Yang","year":"2024","unstructured":"Yang L, Guttman L, Dawson VL, et al. Parthanatos: mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke. Biochem Pharmacol. 2024;228:116174. https:\/\/doi.org\/10.1016\/j.bcp.2024.116174.","journal-title":"Biochem Pharmacol"},{"key":"7970_CR16","doi-asserted-by":"publisher","unstructured":"Li X, Zhou Q, Zhang X, et al. STING-ERO1 signaling exacerbates PARylation-mediated parthanatos in sepsis. Cell Commun Signal. 2026;24(1). https:\/\/doi.org\/10.1186\/s12964-026-02791-6.","DOI":"10.1186\/s12964-026-02791-6"},{"issue":"3","key":"7970_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10557-024-07545-5","volume":"39","author":"L Hang","year":"2025","unstructured":"Hang L, Zhang Y, Zhang Z, et al. Metabolism serves as a bridge between cardiomyocytes and immune cells in cardiovascular diseases. Cardiovasc Drugs Ther. 2025;39(3):661\u201376. https:\/\/doi.org\/10.1007\/s10557-024-07545-5.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"7970_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/SHK.0000000000001858","volume":"57","author":"BK Shimada","year":"2022","unstructured":"Shimada BK, Boyman L, Huang W, et al. Pyruvate-driven oxidative phosphorylation is downregulated in sepsis-induced cardiomyopathy: a study of mitochondrial proteome. Shock. 2022;57(4):553\u201364. https:\/\/doi.org\/10.1097\/SHK.0000000000001858.","journal-title":"Shock"},{"issue":"4","key":"7970_CR19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/infdis\/jiad365","volume":"229","author":"T Chen","year":"2024","unstructured":"Chen T, Ye L, Zhu J, et al. Inhibition of pyruvate dehydrogenase kinase 4 attenuates myocardial and mitochondrial injury in sepsis-induced cardiomyopathy. J Infect Dis. 2024;229(4):1178\u201388. https:\/\/doi.org\/10.1093\/infdis\/jiad365.","journal-title":"J Infect Dis"},{"issue":"4","key":"7970_CR20","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s10753-024-01981-z","volume":"47","author":"T Chen","year":"2024","unstructured":"Chen T, Xie Q, Tan B, et al. Inhibition of pyruvate dehydrogenase kinase 4 protects cardiomyocytes from lipopolysaccharide-induced mitochondrial damage by reducing lactate accumulation. Inflammation. 2024;47(4):1356\u201370. https:\/\/doi.org\/10.1007\/s10753-024-01981-z.","journal-title":"Inflammation"},{"issue":"13","key":"7970_CR21","doi-asserted-by":"publisher","first-page":"e191649","DOI":"10.1172\/jci.insight.191649","volume":"10","author":"JQ Yap","year":"2025","unstructured":"Yap JQ, Nikouee A, Kim M, et al. Myocardial pyruvate dehydrogenase kinase 4 drives sex-specific cardiac responses to endotoxemia. JCI Insight. 2025;10(13):e191649. https:\/\/doi.org\/10.1172\/jci.insight.191649.","journal-title":"JCI Insight"},{"issue":"4","key":"7970_CR22","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/CIRCRESAHA.124.325708","volume":"137","author":"TN Zhang","year":"2025","unstructured":"Zhang TN, Huang XM, Li L, et al. Lactylation of HADHA promotes sepsis-induced myocardial depression. Circ Res. 2025;137(4):e65\u201387. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.325708.","journal-title":"Circ Res"},{"issue":"15","key":"7970_CR23","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1111\/bph.70478","volume":"183","author":"Y Zhou","year":"2026","unstructured":"Zhou Y, Ma M, Xu C, et al. Ailanthone alleviates septic cardiomyopathy by attenuating MYST histone acetyltransferase 1-mediated H4K16 lactylation-driven inflammation. Br J Pharmacol. 2026;183(15):4364\u201380. https:\/\/doi.org\/10.1111\/bph.70478.","journal-title":"Br J Pharmacol"},{"issue":"10","key":"7970_CR24","doi-asserted-by":"publisher","first-page":"e2412799","DOI":"10.1002\/advs.202412799","volume":"12","author":"Y Yan","year":"2025","unstructured":"Yan Y, Li B, Gao Q, et al. Intestine-decipher engineered capsules protect against sepsis-induced intestinal injury via broad-spectrum anti-inflammation and parthanatos inhibition. Adv Sci (Weinh). 2025;12(10):e2412799. https:\/\/doi.org\/10.1002\/advs.202412799.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"7970_CR25","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.cell.2022.04.020","volume":"185","author":"H Park","year":"2022","unstructured":"Park H, Kam TI, Peng H, et al. PAAN\/MIF nuclease inhibition prevents neurodegeneration in Parkinson\u2019s disease. Cell. 2022;185(11):1943\u2013e195921. https:\/\/doi.org\/10.1016\/j.cell.2022.04.020.","journal-title":"Cell"},{"issue":"13","key":"7970_CR26","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1021\/acs.jmedchem.3c00397","volume":"66","author":"D Chen","year":"2023","unstructured":"Chen D, Osipyan A, Adriana J, et al. Allosteric inhibitors of macrophage migration inhibitory factor (MIF) interfere with apoptosis-inducing factor (AIF) co-localization to prevent parthanatos. J Med Chem. 2023;66(13):8767\u201381. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00397.","journal-title":"J Med Chem"},{"issue":"4","key":"7970_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10557-025-07824-9","volume":"40","author":"X Feng","year":"2026","unstructured":"Feng X, Wang D, Xu C. Lipid-mediated exosomal signaling modulates G6PD-dependent metabolic remodeling in heart failure. Cardiovasc Drugs Ther. 2026;40(4):1233\u20134. https:\/\/doi.org\/10.1007\/s10557-025-07824-9.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"7970_CR28","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1186\/s12967-024-05836-x","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Huang X, Huo H, et al. Deletion of MAPL ameliorates septic cardiomyopathy by mitigating mitochondrial dysfunction. J Transl Med. 2024;22(1):1012. https:\/\/doi.org\/10.1186\/s12967-024-05836-x.","journal-title":"J Transl Med"},{"key":"7970_CR29","doi-asserted-by":"publisher","first-page":"tkac043","DOI":"10.1093\/burnst\/tkac043","volume":"10","author":"C Song","year":"2022","unstructured":"Song C, Zhang Y, Pei Q, et al. HSP70 alleviates sepsis-induced cardiomyopathy by attenuating mitochondrial dysfunction-initiated NLRP3 inflammasome-mediated pyroptosis in cardiomyocytes. Burns Trauma. 2022;10:tkac043. https:\/\/doi.org\/10.1093\/burnst\/tkac043.","journal-title":"Burns Trauma"},{"key":"7970_CR30","doi-asserted-by":"publisher","first-page":"109855","DOI":"10.1016\/j.abb.2023.109855","volume":"752","author":"TT Wan","year":"2024","unstructured":"Wan TT, Li Y, Li JX, et al. ACE2 activation alleviates sepsis-induced cardiomyopathy by promoting MasR-Sirt1-mediated mitochondrial biogenesis. Arch Biochem Biophys. 2024;752:109855. https:\/\/doi.org\/10.1016\/j.abb.2023.109855.","journal-title":"Arch Biochem Biophys"},{"key":"7970_CR31","doi-asserted-by":"publisher","first-page":"156733","DOI":"10.1016\/j.cyto.2024.156733","volume":"182","author":"L Yin","year":"2024","unstructured":"Yin L, Yuan L, Luo Z, et al. COX-2 optimizes cardiac mitochondrial biogenesis and exerts a cardioprotective effect during sepsis. Cytokine. 2024;182:156733. https:\/\/doi.org\/10.1016\/j.cyto.2024.156733.","journal-title":"Cytokine"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07970-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:01:18Z","timestamp":1790719278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":31,"alternative-id":["7970"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07970-8","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"31 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Ethics Committee for Laboratory Animals at Quanzhou Medical College (Approval No.: 2024037).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}